跳至主要内容
临床试验/EUCTR2008-005353-38-FR
EUCTR2008-005353-38-FR进行中(未招募)1 期

Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 7 to 11 years, with Major depressive disorder (MDD)

H. Lundbeck A/S0 个研究点目标入组 750 人开始时间: 2016年5月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - The patient is a boy or girl, aged =7 and <12 years at screening (patients who turn 12 years during the study will be allowed to continue in the study).
  • - The patient has Major depressive disorder (MDD), diagnosed according to DSM-5™.
  • - The patient has a CDRS-R total score =45 at the Screening Visit and the Baseline Visit.
  • - The patient has a CGI-S score =4 at the Screening Visit and the Baseline Visit.
  • - The patient has provided assent to participation and parent(s)/legal representative (s) signed the Informed Consent Form.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 750
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - The patient has participated in a clinical study <30 days prior to the Screening Visit.

研究者

相似试验

进行中(未招募)
1 期
A study to evaluate the effect of a product named vortioxetine (used in depression) in children. These effects will be compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.MedDRA version: 21.1Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005353-38-PLH. Lundbeck A/S770
进行中(未招募)
1 期
A study to evaluate the effect of a product named vortioxetine (used in depression) in adolescents. These effects will be compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.MedDRA version: 19.0 Level: PT Classification code 10057840 Term: Major depression System Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005354-20-FRH. Lundbeck A/S750
进行中(未招募)
1 期
A study to evaluate the effect of a product named vortioxetine (used in depression) in children. These effects will be compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.MedDRA version: 20.0Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005353-38-HUH. Lundbeck A/S750
进行中(未招募)
1 期
A study to evaluate the effect of a product named vortioxetine (used in depression) in adolescents. These effects will be compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.MedDRA version: 20.0 Level: PT Classification code 10057840 Term: Major depression System Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005354-20-HUH. Lundbeck A/S750
进行中(未招募)
1 期
A study to evaluate the effect of a product named vortioxetine (used in depression) in adolescents. These effects will be compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.MedDRA version: 20.0 Level: PT Classification code 10057840 Term: Major depression System Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005354-20-BGH. Lundbeck A/S750
A study to evaluate the effect of a product named... | 临床试验